These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

830 related items for PubMed ID: 17597103

  • 1. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.
    Int J Cancer; 2007 Nov 15; 121(10):2181-91. PubMed ID: 17597103
    [Abstract] [Full Text] [Related]

  • 2. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M.
    Clin Cancer Res; 2008 Sep 01; 14(17):5459-65. PubMed ID: 18765537
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M.
    Cancer Res; 2006 Mar 01; 66(5):2650-7. PubMed ID: 16510584
    [Abstract] [Full Text] [Related]

  • 4. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM, Tsai CH, Hung WC.
    Oncotarget; 2015 Jun 20; 6(17):14940-52. PubMed ID: 25909285
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ, Opeskin K, Coso S, Wu D, Baldwin ME, Williams ED.
    Prostate; 2013 May 20; 73(6):563-72. PubMed ID: 23038639
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A, Ersöz C, Karasoy D, Sak S.
    Adv Clin Exp Med; 2017 May 20; 26(2):245-249. PubMed ID: 28791841
    [Abstract] [Full Text] [Related]

  • 7. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K.
    Pathol Int; 2006 May 20; 56(5):256-61. PubMed ID: 16669874
    [Abstract] [Full Text] [Related]

  • 8. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K.
    J Natl Cancer Inst; 2002 Jun 05; 94(11):819-25. PubMed ID: 12048269
    [Abstract] [Full Text] [Related]

  • 9. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N, Harris NC, Roufail S, Paquet-Fifield S, Ishaq M, Streltsov VA, Williams SP, Karnezis T, Stacker SA, Achen MG.
    J Biol Chem; 2016 Dec 30; 291(53):27265-27278. PubMed ID: 27852824
    [Abstract] [Full Text] [Related]

  • 10. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, Majima M, Kitasato H.
    Biomed Pharmacother; 2016 Dec 30; 84():660-665. PubMed ID: 27697638
    [Abstract] [Full Text] [Related]

  • 11. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, Koizumi F.
    Breast Cancer Res; 2011 Jun 21; 13(3):R66. PubMed ID: 21693010
    [Abstract] [Full Text] [Related]

  • 12. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT, Honkonen KM, Hartiala P, Tervala TV, Halonen PJ, Junkkari H, Knuutinen N, Ylä-Herttuala S, Alitalo KK, Saarikko AM.
    Angiogenesis; 2015 Jul 21; 18(3):313-26. PubMed ID: 26018927
    [Abstract] [Full Text] [Related]

  • 13. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Jul 21; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C, Correale C, Gandelli A, Spinelli A, Dejana E, D'Alessio S, Danese S.
    Gastroenterology; 2015 Jun 21; 148(7):1438-51.e8. PubMed ID: 25754161
    [Abstract] [Full Text] [Related]

  • 15. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 21; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 16. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):14-21. PubMed ID: 15632376
    [Abstract] [Full Text] [Related]

  • 17. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S, Helske S, Lappalainen J, Kupari M, Kovanen PT.
    Atherosclerosis; 2012 Apr 05; 221(2):366-74. PubMed ID: 22281299
    [Abstract] [Full Text] [Related]

  • 18. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
    Dong X, Qiu XS, Wang EH, Li QC, Gu W.
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr 05; 32(2):128-32. PubMed ID: 12839674
    [Abstract] [Full Text] [Related]

  • 19. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada AR, Medina MA, Noël A.
    J Hematol Oncol; 2017 Jun 19; 10(1):122. PubMed ID: 28629427
    [Abstract] [Full Text] [Related]

  • 20. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K.
    Am J Pathol; 2008 Dec 19; 173(6):1891-901. PubMed ID: 18988807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.